Get the Stockscreener App
137.50
3.38%
4.49
Pre-market:
138.35
0.85
+0.62%
Mesa Laboratories Inc stock is traded at $137.50, with a volume of 200.41K.
It is up +3.38% in the last 24 hours and up +10.60% over the past month.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
See More
Previous Close:
$133.01
Open:
$132.39
24h Volume:
200.41K
Relative Volume:
1.24
Market Cap:
$769.43M
Revenue:
$249.13M
Net Income/Loss:
$6.71M
P/E Ratio:
113.86
EPS:
1.2076
Net Cash Flow:
$39.58M
1W Performance:
+8.15%
1M Performance:
+10.60%
6M Performance:
+69.48%
1Y Performance:
+107.05%
1-Day Range:
$130.53
$138.66
1-Week Range:
$124.50
$138.66
52-Week Range:
$63.48
$138.66
Mesa Laboratories Inc Stock (MLAB) Company Profile
Name
Mesa Laboratories Inc
Sector
Phone
(303) 987-8000
Address
12100 W 6TH AVE, LAKEWOOD
Compare MLAB vs KEYS, COHR, GRMN, TDY, MKSI
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MLAB
Mesa Laboratories Inc
|
137.50 | 769.43M | 249.13M | 6.71M | 39.58M | 1.2076 |
KEYS
Keysight Technologies Inc
|
357.54 | 60.87B | 6.09B | 1.07B | 1.36B | 6.0693 |
COHR
Coherent Corp
|
290.61 | 56.91B | 6.60B | 452.58M | -538.24M | 2.0946 |
GRMN
Garmin Ltd
|
295.04 | 56.90B | 7.46B | 1.74B | 1.45B | 8.9685 |
TDY
Teledyne Technologies Inc
|
612.02 | 28.37B | 6.22B | 933.70M | 1.05B | 19.76 |
MKSI
Mks Inc
|
257.98 | 17.44B | 4.07B | 328.00M | 380.00M | 4.7842 |
Mesa Laboratories Inc Stock (MLAB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-04-21 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Oct-02-20 | Initiated | JP Morgan | Neutral |
| Dec-04-19 | Initiated | Jefferies | Buy |
| Aug-26-19 | Initiated | Evercore ISI | Outperform |
| Jun-10-16 | Downgrade | Sidoti | Buy → Neutral |
View All
Mesa Laboratories Inc Stock (MLAB) Latest News
Understanding Momentum Shifts in (MLAB) - news.stocktradersdaily.com
Mesa Laboratories Director Capone Mark Christopher Granted 2,423 Derivative Securities on September 9, 2026 - Kalkine Media
MESA LABORATORIES INC /CO/ Director Tripeny R Tony Granted 1,774 Derivative Securities on September 9, 2026 - Kalkine Media
Mesa Laboratories Director Mark Capone Awarded 2,423 RSUs with 2027 Vesting - Kalkine Media
Mesa Laboratories (MLAB) awards stock units vesting in 2027 to a director - Stock Titan
Mesa Laboratories (MLAB) awards director RSUs vesting in 2027 - Stock Titan
Director at Mesa Laboratories (NASDAQ: MLAB) granted 1,774 stock units - Stock Titan
Director awarded 1,774 RSUs at Mesa Laboratories (MLAB) - Stock Titan
Mesa Laboratories (MLAB) gives director stock units vesting in 2027 - Stock Titan
Director at Mesa Laboratories (NASDAQ: MLAB) receives new stock unit grant - Stock Titan
Mesa Laboratories Announces Certified Shareholder Voting Outcomes from September 2026 Annual Meeting - Kalkine Media
Mesa Laboratories shareholders vote on director slate at annual meeting - Bitget
Mesa Laboratories (MLAB) Slides 2.2% to $124.94, Approaching Key Support ZoneATR Stop - siam.in
Mesa Laboratories Inc. (MLAB) Peer Comparison – Compare with Others - Value Research
Mesa Laboratories Inc. (MLAB) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Mesa Laboratories Inc (MLAB) Shares Surge 4.1% -- What GF Score of 75 Tells Investors - gurufocus.com
Mesa Laboratories stock sets a new 52-week high. Dividend date lands August 31, 2026. - ad-hoc-news.de
Former Mesa Labs (NASDAQ: MLAB) officer may sell shares from stock awards - Stock Titan
Mesa (MLAB) Earnings Update: EPS Comes in Above Forecast in the Current Update; Session Move: The Stock Records a 0.35% Decrease in the Current UpdateRevenue Per Share - vinanet.vn
Is Mesa Laboratories Inc (MLAB) Overvalued After 4.5% Rally? GF - GuruFocus
Former Mesa Labs (MLAB) exec files notice for August stock sale - Stock Titan
Mesa Laboratories (MLAB) Q1 2027 Earnings Call Transcript - AOL.com
Mesa Laboratories (NASDAQ:MLAB) Reaches New 52-Week HighWhat's Next? - MarketBeat
Mesa (MLAB) Results Versus Estimates: The Bottom-Line Figure Outpaces Its Comparison at the Close; Share Response: The Market Price Advances 0.28% in Latest TradingEPS Growth Rate - Vinanet
Mesa (MLAB) Quarterly Update: Profit Per Share Surpasses Its Benchmark at the Close; Immediate Response - vinanet.vn
Mesa (MLAB) Technical Snapshot: Finishes 0.33% Up at $107.99; Boundary Check: Price Remains Between $102.59 Support and $113.39 Resistance on the DayVolume Breadth - vinanet.vn
Mesa Labs director John Sullivan sells $800,090 in stock By Investing.com - Investing.com Nigeria
Mesa Laboratories Director Shiraz Ladiwala Receives 3,810 Shares from RSU Vesting on August 15, 2026 - Kalkine Media
Mesa Laboratories (NASDAQ: MLAB) director adds 2,784 shares via RSU vesting - Stock Titan
Mesa Labs (NASDAQ: MLAB) director adds 2,784 shares from RSUs - Stock Titan
Mesa Labs (NASDAQ: MLAB) director settles 3,810 RSUs into stock - Stock Titan
Mesa Laboratories (NASDAQ: MLAB) director now holds 6,973 shares - Stock Titan
Mesa Laboratories (NASDAQ: MLAB) director adds stock via RSU vesting - Stock Titan
Mesa Labs (MLAB) director’s equity grant adds 2,784 shares - Stock Titan
Mesa Laboratories Director John James Sullivan Sells 7,093 Shares Privately to CEO - Kalkine Media
Mesa Laboratories CEO Kadia buys $800,090 in stock By Investing.com - Investing.com South Africa
Siddhartha Kadia Buys 7,093 Shares of Mesa Laboratories (NASDAQ:MLAB) Stock - MarketBeat
R Tony Tripeny Acquires 900 Shares of Mesa Laboratories (NASDAQ:MLAB) Stock - MarketBeat
Mesa Labs director John Sullivan sells $800,090 in stock - Investing.com
MLAB Q2 2026 Earnings: EPS of $2.61 Crushes Estimates by 8,429%Pretax Income Report - vinanet.vn
Mesa Laboratories CEO Kadia buys $800,090 in stock - Investing.com
Mesa Laboratories (NASDAQ: MLAB) director sells shares to CEO - Stock Titan
Mesa Laboratories (NASDAQ: MLAB) director lifts stake to 6,298 shares - Stock Titan
Diamond Hill Capital Management LLC Investment Advisor Makes New Investment in Mesa Laboratories, Inc. $MLAB - MarketBeat
Mesa Laboratories (NASDAQ:MLAB) Rating Lowered to Buy at Wall Street Zen - MarketBeat
Mesa Laboratories (NASDAQ:MLAB) Stock Price Down 6%Time to Sell? - MarketBeat
Mesa Laboratories (NASDAQ:MLAB) Given New $110.00 Price Target at Wells Fargo & Company - MarketBeat
Mesa Laboratories (NASDAQ:MLAB) Hits New 12-Month HighHere's Why - MarketBeat
Wasatch Advisors LP Increases Position in Mesa Laboratories, Inc. $MLAB - MarketBeat
Mesa Labs (NASDAQ: MLAB) CEO trust buys shares from board chair - Stock Titan
Mesa Laboratories (MLAB) Stock Jumps As Margin Gains Meet Backlog Doubts - Sahm
Mesa Laboratories Inc Stock (MLAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):